Oncology phase II
A Prospective, Multicenter Study, to Evaluate the Efficacy and Safety of [18F]-ML-10, a PET Imaging Radiotracer, in Early Detection of Response of Non-Hematological Tumors to Concurrent Chemoradiotherapy
Read More
|
Oncology (Phase II)
An Open-Label, Multi-Center Study to Evaluate the Efficacy and Safety of [18F]-ML-10 as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy
Read More
|
Oncology (Phase II)
An Open-label Phase II Study, to Evaluate [18F]-ML-10 as a PET Imaging Radiotracer for Early Detection of Response of Brain Metastases to Whole-Brain Radiation Therapy
Read More
|
Stroke (Phase II)
An Open-label Phase II Study to Assess the Suitability of [18F]-ML-10 for Imaging of Cell Death in the Region of the Cerebral Infarct in Patients With Ischemic Stroke Using Positron Emission Tomography (PET) Imaging
Read More
|
Healthy volunteers (Phase I)
An Open-label Phase I Study to Assess Safety, Dosimetry and Biodistribution of 18F-ML-10 in Healthy Volunteers
Read More
|